Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-07
DOI
10.1186/s13045-020-00998-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of chimeric antigen receptor NK-92 cells to target mesothelin in ovarian cancer
- (2020) Bihui Cao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tissue factor as a new target for CAR-NK cell immunotherapy of triple-negative breast cancer
- (2020) Zhiwei Hu Scientific Reports
- Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function
- (2020) Gustavo Rodrigues Rossi et al. Frontiers in Immunology
- Targeting Natural Killer Cells for Tumor Immunotherapy
- (2020) Cai Zhang et al. Frontiers in Immunology
- Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs)
- (2020) Julia Hambach et al. Cells
- Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
- (2020) Hanren Dai et al. Journal of Hematology & Oncology
- PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations
- (2020) Kellsye P Fabian et al. Journal for ImmunoTherapy of Cancer
- Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
- (2020) Tsutomu Nakazawa et al. Cells
- Targeting epidermal growth factor‐overexpressing triple‐negative breast cancer by natural killer cells expressing a specific chimeric antigen receptor
- (2020) Yan Liu et al. CELL PROLIFERATION
- A novel chimeric PD1-NKG2D-41BB receptor enhances antitumor activity of NK92 cells against human lung cancer H1299 cells by triggering pyroptosis
- (2020) Chengui Lu et al. MOLECULAR IMMUNOLOGY
- Roles of NK Cell Receptors 2B4 (CD244), CS1 (CD319), and LLT1 (CLEC2D) in Cancer
- (2020) Casey W. Buller et al. Cancers
- Anti-PSMA CAR-Engineered NK-92 Cells: An Off-the-Shelf Cell Therapy for Prostate Cancer
- (2020) Isabella Monia Montagner et al. Cells
- NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors
- (2019) Robin Parihar et al. Cancer Immunology Research
- Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
- (2019) Gaurav Nayyar et al. Frontiers in Oncology
- Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies
- (2019) Benjamin Heyman et al. Cancers
- Engineering and Design of Chimeric Antigen Receptors
- (2019) Sonia Guedan et al. Molecular Therapy-Methods & Clinical Development
- Physical principles of retroviral integration in the human genome
- (2019) D. Michieletto et al. Nature Communications
- Immunogenomic correlates of response to cetuximab monotherapy in head and neck squamous cell carcinoma
- (2019) Daniel L. Faden et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Toxicities of CD19 CAR-T cell immunotherapy
- (2019) Alexandre V. Hirayama et al. AMERICAN JOURNAL OF HEMATOLOGY
- Immunogenicity of Chimeric Antigen Receptor T-Cell Therapeutics
- (2019) Boris Gorovits et al. BIODRUGS
- Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy
- (2019) Stefan Stoiber et al. Cells
- Genetic Reprogramming For NK cell Cancer Immunotherapy with CRISPR /Cas9
- (2019) Lukman O. Afolabi et al. IMMUNOLOGY
- Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
- (2019) John K. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Target selection for CAR-T therapy
- (2019) Jianshu Wei et al. Journal of Hematology & Oncology
- The mechanism of anti-PD-L1 antibody efficacy against PD-L1 negative tumors identifies NK cells expressing PD-L1 as a cytolytic effector
- (2019) Wenjuan Dong et al. Cancer Discovery
- Robo1-specific CAR-NK Immunotherapy Enhances Efficacy of 125I Seed Brachytherapy in an Orthotopic Mouse Model of Human Pancreatic Carcinoma
- (2019) NING XIA et al. ANTICANCER RESEARCH
- Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors
- (2019) Rachel Grosser et al. CANCER CELL
- NK cell-based therapeutics for lung cancer
- (2019) A. Graham Pockley et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy
- (2019) Lucía Fernández et al. Frontiers in Immunology
- Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
- (2019) Olli Dufva et al. BLOOD
- Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
- (2018) Ye Li et al. Cell Stem Cell
- A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome
- (2018) Fevzi Firat Yalniz et al. Clinical Lymphoma Myeloma & Leukemia
- Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells
- (2018) Wei Xiong et al. MOLECULAR THERAPY
- Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models
- (2018) Folashade Otegbeye et al. PLoS One
- A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies
- (2018) Norbert Vey et al. Oncotarget
- Enhanced cancer immunotherapy with Smad3-slilencing NK-92 cells
- (2018) Qing Ming Wang et al. Cancer Immunology Research
- Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
- (2018) Arash Nanbakhsh et al. Jove-Journal of Visualized Experiments
- Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins
- (2018) Meisam Naeimi Kararoudi et al. Jove-Journal of Visualized Experiments
- Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
- (2018) Rohtesh S. Mehta et al. Frontiers in Immunology
- CD22: A Regulator of Innate and Adaptive B Cell Responses and Autoimmunity
- (2018) Edward A. Clark et al. Frontiers in Immunology
- Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells
- (2018) Jiao Wang et al. Journal for ImmunoTherapy of Cancer
- Allogeneic CAR-T Cells: More than Ease of Access?
- (2018) Charlotte Graham et al. Cells
- Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells
- (2017) Stephan Klöß et al. HUMAN GENE THERAPY
- The Broad Spectrum of Human Natural Killer Cell Diversity
- (2017) Aharon G. Freud et al. IMMUNITY
- Natural Killer Cells: Angels and Devils for Immunotherapy
- (2017) Beatriz Martín-Antonio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recent developments in immunotherapy of acute myeloid leukemia
- (2017) Felix S. Lichtenegger et al. Journal of Hematology & Oncology
- Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukemia
- (2017) Mingxue Fan et al. Journal of Hematology & Oncology
- Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
- (2017) E Liu et al. LEUKEMIA
- Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers
- (2017) Elizabeth L. Siegler et al. MOLECULAR THERAPY
- Quantitative Imaging Approaches to Study the CAR Immunological Synapse
- (2017) Malini Mukherjee et al. MOLECULAR THERAPY
- Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer
- (2017) Somala Mohammed et al. MOLECULAR THERAPY
- Concise Review: Emerging Principles from the Clinical Application of Chimeric Antigen Receptor T Cell Therapies for B Cell Malignancies
- (2017) Michael D. Jain et al. STEM CELLS
- Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy
- (2017) Dominique Bollino et al. Translational Research
- Erratum: Acute myeloid leukemia targets for bispecific antibodies
- (2017) S S Hoseini et al. Blood Cancer Journal
- Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9
- (2017) Jiangtao Ren et al. Protein & Cell
- Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
- (2017) Meriem Messaoudene et al. Frontiers in Immunology
- Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice
- (2017) Yaya Chu et al. OncoImmunology
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- A TCR-based Chimeric Antigen Receptor
- (2017) Even Walseng et al. Scientific Reports
- The Innate Lymphoid Cell Precursor
- (2016) Isabel E. Ishizuka et al. Annual Review of Immunology
- CAR-T Cell Therapy for Lymphoma
- (2016) Carlos A. Ramos et al. Annual Review of Medicine
- Chimeric antigen receptor T cell therapy: 25years in the making
- (2016) Saar Gill et al. BLOOD REVIEWS
- Selection and expansion of natural killer cells for NK cell-based immunotherapy
- (2016) Petra S. A. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CRISPR-Cas9-mediated multiplex gene editing in CAR-T cells
- (2016) Xiaojuan Liu et al. CELL RESEARCH
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Checkpoint Inhibition of KIR2D with the Monoclonal Antibody IPH2101 Induces Contraction and Hyporesponsiveness of NK Cells in Patients with Myeloma
- (2016) M. Carlsten et al. CLINICAL CANCER RESEARCH
- Genetically Engineered Natural Killer Cells as a Means for Adoptive Tumor Immunotherapy
- (2016) Susanne Michen et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival
- (2016) Ryan Alkins et al. NEURO-ONCOLOGY
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases
- (2016) Xilin Chen et al. Oncotarget
- Magnetofection Enhances Lentiviral-Mediated Transduction of Airway Epithelial Cells through Extracellular and Cellular Barriers
- (2016) Stefano Castellani et al. Genes
- Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
- (2016) Hans Klingemann et al. Frontiers in Immunology
- Toxicity and management in CAR T-cell therapy
- (2016) Challice L Bonifant et al. Molecular Therapy-Oncolytics
- Disialoganglioside-specific human natural killer cells are effective against drug-resistant neuroblastoma
- (2015) Diana Seidel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
- (2015) D. M. Benson et al. CLINICAL CANCER RESEARCH
- Challenges of cancer therapy with natural killer cells
- (2015) Hans Klingemann CYTOTHERAPY
- Coexpressed Catalase Protects Chimeric Antigen Receptor–Redirected T Cells as well as Bystander Cells from Oxidative Stress–Induced Loss of Antitumor Activity
- (2015) Maarten A. Ligtenberg et al. JOURNAL OF IMMUNOLOGY
- DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
- (2015) Katrin Töpfer et al. JOURNAL OF IMMUNOLOGY
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
- (2015) Nadja Müller et al. JOURNAL OF IMMUNOTHERAPY
- Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions
- (2015) Simone Battella et al. JOURNAL OF LEUKOCYTE BIOLOGY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Dielectrophoresis-assisted 3D nanoelectroporation for non-viral cell transfection in adoptive immunotherapy
- (2015) Lingqian Chang et al. LAB ON A CHIP
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
- (2015) Kurt Schönfeld et al. MOLECULAR THERAPY
- HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells
- (2015) Anjie Zhen et al. MOLECULAR THERAPY
- Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
- (2015) Richard W. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- The pharmacology of second-generation chimeric antigen receptors
- (2015) Sjoukje J. C. van der Stegen et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
- (2015) David L. Porter et al. Science Translational Medicine
- Engineering CAR-T cells: Design concepts
- (2015) Shivani Srivastava et al. TRENDS IN IMMUNOLOGY
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Advantages and applications of CAR-expressing natural killer cells
- (2015) Wolfgang Glienke et al. Frontiers in Pharmacology
- Utilizing Chimeric Antigen Receptors to Direct Natural Killer Cell Activity
- (2015) David L. Hermanson et al. Frontiers in Immunology
- Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
- (2015) Mattias Carlsten et al. Frontiers in Immunology
- How to outsmart NK cell tolerance
- (2015) Grzegorz Terszowski et al. OncoImmunology
- CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
- (2015) Jianfeng Han et al. Scientific Reports
- Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15
- (2014) M. Imamura et al. BLOOD
- Current concepts in the diagnosis and management of cytokine release syndrome
- (2014) D. W. Lee et al. BLOOD
- CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
- (2014) Erik Wennerberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin 12: still a promising candidate for tumor immunotherapy?
- (2014) Witold Lasek et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Anti-CD20 chimeric antigen receptor (CAR) modified expanded natural killer (NK) cells significantly mediate rituximab sensitive and resistant burkitt lymphoma (BL) regression and improve survival in human BL xenografted NSG mice
- (2014) Y. Chu et al. CYTOTHERAPY
- A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma
- (2014) N. Korde et al. HAEMATOLOGICA
- Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF
- (2014) Weizhou Hou et al. INTERNATIONAL JOURNAL OF CANCER
- Target Antigen Density Governs the Efficacy of Anti–CD20-CD28-CD3 ζ Chimeric Antigen Receptor–Modified Effector CD8+T Cells
- (2014) Keisuke Watanabe et al. JOURNAL OF IMMUNOLOGY
- The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions
- (2014) Christopher J Chan et al. NATURE IMMUNOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhanced Cytotoxicity of Natural Killer Cells following the Acquisition of Chimeric Antigen Receptors through Trogocytosis
- (2014) Fu-Nan Cho et al. PLoS One
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
- (2014) P. S. Adusumilli et al. Science Translational Medicine
- T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression
- (2014) S. P. Santoro et al. Cancer Immunology Research
- Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
- (2014) Cristina Eguizabal et al. Frontiers in Immunology
- Trial Watch
- (2014) Fernando Aranda et al. OncoImmunology
- Are natural killer cells superior CAR drivers?
- (2014) Hans Klingemann OncoImmunology
- Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
- (2013) H. E. Kohrt et al. BLOOD
- Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy
- (2013) S. A. Lim et al. CANCER RESEARCH
- A Chimeric Receptor with NKG2D Specificity Enhances Natural Killer Cell Activation and Killing of Tumor Cells
- (2013) Y.-H. Chang et al. CANCER RESEARCH
- NK cell-based immunotherapy for malignant diseases
- (2013) Min Cheng et al. Cellular & Molecular Immunology
- Treatment of patients with advanced cancer with the natural killer cell line NK-92
- (2013) Torsten Tonn et al. CYTOTHERAPY
- Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC
- (2013) Mirna Balsamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Hematopoietic stem cells for cancer immunotherapy
- (2013) Eric Gschweng et al. IMMUNOLOGICAL REVIEWS
- Design and development of therapies using chimeric antigen receptor-expressing T cells
- (2013) Gianpietro Dotti et al. IMMUNOLOGICAL REVIEWS
- Retargeting NK-92 for anti-melanoma activity by a TCR-like single-domain antibody
- (2013) Ge Zhang et al. IMMUNOLOGY AND CELL BIOLOGY
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Cancer Gene Discovery: Exploiting Insertional Mutagenesis
- (2013) Marco Ranzani et al. MOLECULAR CANCER RESEARCH
- Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
- (2013) Hua Jiang et al. Molecular Oncology
- Treatment of Metastatic Renal Cell Carcinoma With CAIX CAR-engineered T cells: Clinical Evaluation and Management of On-target Toxicity
- (2013) Cor HJ Lamers et al. MOLECULAR THERAPY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Narrow-Spectrum HDAC Inhibitor Entinostat Enhances NKG2D Expression Without NK Cell Toxicity, Leading to Enhanced Recognition of Cancer Cells
- (2013) Shiguo Zhu et al. PHARMACEUTICAL RESEARCH
- Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice
- (2013) Jeannette Cany et al. PLoS One
- Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
- (2013) Nina Shah et al. PLoS One
- Location and cellular stages of natural killer cell development
- (2013) Jianhua Yu et al. TRENDS IN IMMUNOLOGY
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity
- (2013) Laurent Boissel et al. OncoImmunology
- Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
- (2012) Christiane Sahm et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies
- (2012) Noriko Shimasaki et al. CYTOTHERAPY
- Inhibition of Intracellular Antiviral Defense Mechanisms Augments Lentiviral Transduction of Human Natural Killer Cells: Implications for Gene Therapy
- (2012) Tolga Sutlu et al. HUMAN GENE THERAPY
- Dacarbazine-Mediated Upregulation of NKG2D Ligands on Tumor Cells Activates NK and CD8 T Cells and Restrains Melanoma Growth
- (2012) Alice Hervieu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects
- (2012) Padma Sampath et al. MOLECULAR THERAPY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Natural killer cell lines in tumor immunotherapy
- (2012) Min Cheng et al. Frontiers of Medicine
- High CD33 expression levels in acute myeloid leukemia cells carrying the nucleophosmin (NPM1) mutation
- (2011) M. S. De Propris et al. HAEMATOLOGICA
- The unique profile of cord blood natural killer cells balances incomplete maturation and effective killing function upon activation
- (2011) Martha Luevano et al. HUMAN IMMUNOLOGY
- NK cells engineered to express a GD2-specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin
- (2011) Ruth Esser et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Comparison of mRNA and lentiviral based transfection of natural killer cells with chimeric antigen receptors recognizing lymphoid antigens
- (2011) Laurent Boissel et al. LEUKEMIA & LYMPHOMA
- Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process
- (2011) Jan Spanholtz et al. PLoS One
- NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects
- (2010) J. A. Olson et al. BLOOD
- Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
- (2010) Tolga Sutlu et al. CYTOTHERAPY
- Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b
- (2010) John A. Craddock et al. JOURNAL OF IMMUNOTHERAPY
- Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That Is Reversed With IL-2 Exvivo Expansion
- (2010) Dongxia Xing et al. JOURNAL OF IMMUNOTHERAPY
- Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging
- (2010) Reinhard Meier et al. MAGNETIC RESONANCE IN MEDICINE
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
- (2009) P. S. Woll et al. BLOOD
- Expression of chimeric antigen receptors in natural killer cells with a regulatory-compliant non-viral method
- (2009) L Li et al. CANCER GENE THERAPY
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells
- (2009) B. Altvater et al. CLINICAL CANCER RESEARCH
- 4-1BB and CD28 Signaling Plays a Synergistic Role in Redirecting Umbilical Cord Blood T Cells Against B-Cell Malignancies
- (2009) Syam Tammana et al. HUMAN GENE THERAPY
- Transfection with mRNA for CD19 specific chimeric antigen receptor restores NK cell mediated killing of CLL cells
- (2009) Laurent Boissel et al. LEUKEMIA RESEARCH
- Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome
- (2009) Barbara Felice et al. PLoS One
- Disease-specific analyses of unrelated cord blood transplantation compared with unrelated bone marrow transplantation in adult patients with acute leukemia
- (2008) Y. Atsuta et al. BLOOD
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
- (2008) E. D. Hsi et al. CLINICAL CANCER RESEARCH
- Targeted Cellular Therapy with Natural Killer Cells
- (2008) H. Klingemann et al. HORMONE AND METABOLIC RESEARCH
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
- (2008) Salima Hacein-Bey-Abina et al. JOURNAL OF CLINICAL INVESTIGATION
- Prostate-specific membrane antigen expression in regeneration and repair
- (2008) Ilyssa O Gordon et al. MODERN PATHOLOGY
- Functions of natural killer cells
- (2008) Eric Vivier et al. NATURE IMMUNOLOGY
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas
- (2008) A. Kruschinski et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started